Cosmos Health Reports Record $65.27M Revenue in 2025 with 83% Gross Profit Surge

Key Facts

1Cosmos Health reported record revenue of $65.27 million for 2025, a 20% increase year-over-year.

2Gross profit rose by 83% to $7.90 million, despite a net loss of $19.14 million.

3CEO Greg Siokas acquired over 3.3 million shares of the company.

Cosmos Health Inc. (COSM) reported record 2025 revenue of $65.27 million, driven by an 83% surge in gross profit and significant operational expansion across its Sky Premium Life and Cana Laboratories divisions. In a strategic update, the company announced the integration of AI across its operations, which is projected to decrease certain operating expenses by up to 30%. These AI investments are specifically aimed at enhancing efficiency, reducing costs, and improving customer experience to drive further sales growth. The company's R&D pipeline also remains active with its CCX0722 weight management product entering final development. Despite scaling-related losses, the outlook is supported by a $300 million financing facility and substantial share purchases by CEO Greg Siokas.

5 months ago

Version History

Version 35 months ago

What changed: Updated to include the company's announcement regarding AI integration and its potential to reduce operating expenses by 30%.

Version 25 months ago

What changed: The report was updated to include specific operational metrics regarding SKU expansion, Cana Laboratories manufacturing contracts, the development stage of the CCX0722 weight management product, and the quantification of gross margin expansion in basis points.

Version 15 months ago

What changed: Updated to include the 10x increase in cash reserves, 82% improvement in Adjusted EPS, and the launch of a $300M digital asset treasury strategy.